The Valley Desk

NCT02076178 · Interventional trial

Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)

Overall registry status Completed

Phase 2

Conditions Infection, Human Immunodeficiency Virus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov